Cytogenix (fka CYGX)

[gutaquest]

david, The VC picture doesn't have to be as negative as you have painted it.

Nor should this company continue to "bumble along" until they succeed or fail.

If synDNA proves to be what the management of CYGX has reported it to be, CYGX management will be in the drivers seat to cut a good deal for capital to bring synDNA to the commercial market. With a revenue stream from synDNA, CYGX can then follow with ssDNA vaccines and medicines using synDNA as the production base.

The CYGX management is in control right now and will need to make the right decisions to make CYGX a successful company.

Gutaquest